About: Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
Creator	Pal, Rimesh Bhadada, Sanjay
source	Elsevier; Medline; PMC
abstract	covid:f72471977c1c83a8985b482d8890212828fc8e2c#abstract
has issue date	2020-04-10(xsd:dateTime)
bibo:doi	10.1016/j.diabres.2020.108146
bibo:pmid	32283128
has license	els-covid
sha1sum (hex)	f72471977c1c83a8985b482d8890212828fc8e2c
schema:url	https://doi.org/10.1016/j.diabres.2020.108146
resource representing a document's title	Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
has PubMed Central identifier	PMC7151403
has PubMed identifier	32283128
schema:publication	Diabetes Res Clin Pract
resource representing a document's body	covid:f72471977c1c83a8985b482d8890212828fc8e2c#body_text
is schema:about of	named entity 'COVID-19' named entity 'anti-diabetic medications' named entity 'COVID-19 pandemic' named entity 'COVID' named entity 'insulin' »more»

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software